Sandoz Strikes $500m Deal For GSK Cephalosporins

Deal To Acquire Cephalosporins Business Reinforces Position In Antibiotics

 
• By David Wallace
  
GSK Logo Website Magnifying Glass
Sandoz will pay up to $500m for the GSK cephalosporins business • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business